Mediterranean Towers Ltd. (MDTR.TA)
ILA 1127.0
(1.35%)
ILA 1127.0
(1.35%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 6.8 Million | 112.74 Million | 173.59 Million | 42.77 Million | 162.27 Million | 167.06 Million |
| Net Income | 245.57 Million | 141.34 Million | 343.95 Million | -11.96 Million | 101.36 Million | 77.74 Million |
| Depreciation & Amortization | 1.15 Million | 15.25 Million | 1.97 Million | 1.81 Million | 1.41 Million | 997 Thousand |
| Deferred income taxes | -290.74 Million | -268.56 Million | -398.84 Million | 6.14 Million | -121.27 Million | -100.81 Million |
| Stock-based compensation | 304 Thousand | 550 Thousand | 665 Thousand | 924 Thousand | 1.82 Million | 2.26 Million |
| Change in working capital | 26.39 Million | 147.76 Million | 210.6 Million | 62.14 Million | 193.77 Million | 193.02 Million |
| Other non-cash items | 24.11 Million | 76.4 Million | 15.23 Million | -16.29 Million | -14.83 Million | -6.15 Million |
| Investing Cash Flow | -207.88 Million | -271.05 Million | -45.96 Million | -38.02 Million | -81.74 Million | -41.94 Million |
| Investments in PPE | -411 Thousand | -846 Thousand | -700 Thousand | -1.35 Million | -914 Thousand | -2.74 Million |
| Acquisitions | -183.53 Million | - | - | -3 Million | -36.17 Million | -64 Million |
| Investment purchases | -290 Thousand | -70.24 Million | -19.32 Million | -1.11 Million | -624 Thousand | -3.79 Million |
| Sales/Maturities of investments | 66.28 Million | - | - | 3 Million | -26.48 Million | 28.66 Million |
| Other Investing Activities | -89.93 Million | -199.95 Million | -25.93 Million | -35.56 Million | -17.54 Million | -73 Thousand |
| Financing Cash Flow | 219.64 Million | -106.9 Million | -106.21 Million | 228.5 Million | -33.81 Million | -77.33 Million |
| Debt repayment | -144.15 Million | -2.07 Million | -1.98 Million | -104.39 Million | -312 Million | -7.44 Million |
| Dividends payments | -60 Million | -80 Million | -80 Million | - | -50 Million | -50 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | 39.93 Million | - |
| Other Financing Activities | -24.67 Million | -24.82 Million | -24.23 Million | 332.89 Million | 288.25 Million | -19.88 Million |
| Accounts receivables | -835 Thousand | -2.63 Million | -1.06 Million | -345 Thousand | -679 Thousand | -1.38 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 27.23 Million | 150.4 Million | 211.66 Million | 62.48 Million | 194.44 Million | 195.74 Million |
| Cash at beginning of period | 279.42 Million | 544.63 Million | 523.21 Million | 289.95 Million | 243.24 Million | 195.44 Million |
| Cash at end of period | 297.99 Million | 279.42 Million | 544.63 Million | 523.21 Million | 289.95 Million | 243.24 Million |
| Capital Expenditure | -411 Thousand | -846 Thousand | -700 Thousand | -1.35 Million | -914 Thousand | -2.74 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 18.57 Million | -265.2 Million | 21.41 Million | 233.25 Million | 46.71 Million | 47.79 Million |
| Free Cash Flow | 6.39 Million | 111.9 Million | 172.89 Million | 41.42 Million | 161.35 Million | 164.32 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 35.69 Million | 61.81 Million | 115.87 Million | 245.57 Million | 9.32 Million | 50.96 Million |
| Depreciation & Amortization | 191 Thousand | 199 Thousand | 203 Thousand | 1.15 Million | 230 Thousand | 398 Thousand |
| Deferred income taxes | - | - | -107.67 Million | -290.74 Million | -17.5 Million | -77.42 Million |
| Stock-based compensation | 1.47 Million | 488 Thousand | 61 Thousand | 304 Thousand | 60 Thousand | 74 Thousand |
| Change in working capital | 19.78 Million | 19.35 Million | 23.78 Million | 26.39 Million | 7.25 Million | -10.83 Million |
| Other non-cash items | 24.28 Million | -7.58 Million | -10.6 Million | 24.11 Million | 2.66 Million | 19.45 Million |
| Investing Cash Flow | -29.42 Million | 8.9 Million | -30.72 Million | -207.88 Million | -109.41 Million | -14.98 Million |
| Investments in PPE | -17 Thousand | -42 Thousand | -40 Thousand | -411 Thousand | -83 Thousand | -242 Thousand |
| Acquisitions | - | - | - | -183.53 Million | - | - |
| Investment purchases | - | - | 90 Million | -290 Thousand | -90 Million | -290 Thousand |
| Sales/Maturities of investments | - | - | - | 66.28 Million | 66.51 Million | 689 Thousand |
| Other Investing Activities | -29.41 Million | 8.94 Million | -120.69 Million | -89.93 Million | -85.83 Million | -15.13 Million |
| Financing Cash Flow | -79.53 Million | 19.42 Million | 7.6 Million | 219.64 Million | 250.73 Million | -83.6 Million |
| Debt repayment | -13 Million | -19.44 Million | -552 Thousand | -144.15 Million | -121.23 Million | -21.83 Million |
| Dividends payments | -80 Million | - | - | -60 Million | - | -60 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -12.53 Million | -13 Thousand | -13.84 Million | -24.67 Million | 371.96 Million | -1.76 Million |
| Accounts receivables | -1.27 Million | 2.14 Million | -1.43 Million | -835 Thousand | -1.37 Million | -1.65 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 22.43 Million | 17.44 Million | 25.22 Million | 27.23 Million | 8.62 Million | -9.18 Million |
| Cash at beginning of period | 348.08 Million | 297.99 Million | 299.46 Million | 279.42 Million | 156.12 Million | 272.07 Million |
| Cash at end of period | 260.95 Million | 348.08 Million | 297.99 Million | 297.99 Million | 299.46 Million | 156.12 Million |
| Capital Expenditure | -17 Thousand | -42 Thousand | -40 Thousand | -411 Thousand | -83 Thousand | -242 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -87.13 Million | 50.09 Million | -1.47 Million | 18.57 Million | 143.34 Million | -115.95 Million |
| Free Cash Flow | 21.81 Million | 21.71 Million | 21.61 Million | 6.39 Million | 1.94 Million | -17.61 Million |
RITM-PA
138A
R4
ORCHPHARMA
SKHCF
CDGLY